Drug And Gene Delivery Devices Market Growth & Trends
The global drug and gene delivery devices market size is expected to reach USD 1.22 billion by 2030, registering a CAGR of 9.0% from 2024 to 2030. Rising investment by the market players to develop innovative drug delivery systems to cater to the demand by the patients as well as to increase the bioavailability at minimum quantity of active pharmaceutical ingredient is driving the market growth. Additionally, increasing focus on R&D of gene delivery systems owing to the high growth potential of gene therapy for the treatment of a wide range of diseases is expected to fuel the market growth in the future.
Drug delivery systems are in a constant evolution along with the changing preference by the patient. For instance, initially, hormone replacement therapy was widely prescribed in the form of pills, whereas, it is now available in the form of prefilled syringes, patches, vaginal rings, gel, and sprays. The principal purpose of development of different forms of delivery systems is to increase the ease of use. Factors such as aesthetics of the delivery systems, price, and amount of API are also considered while designing the drug delivery system.
Drug And Gene Delivery Devices Market Report Highlights
- In 2023, the oral segment dominated the market and accounted for the largest revenue share of 52.7%, owing to its convenience and ease of administration.
- The injectable segment is expected to witness the fastest CAGR of 11.0% during the forecast period, fueled by increasing prevalence of life-threatening diseases and advancement in injectable drug delivery devices.
- In 2023, North America dominated the drug and gene delivery devices market with a revenue share of 54.0%, owing to the rising number of people suffering from chronic diseases.
- The drug and gene delivery devices market in Asia Pacific is projected to witness growth during the forecast period. The growth can be attributed to the increasing prevalence of chronic diseases such as heart disease, diabetes and cancer owing to the changing lifestyle, increase in consumption of alcohols and cigarettes.
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players worldwide.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
- COVID-19's impact and how to sustain in these fast-evolving markets
This product will be delivered within 2 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Drug and Gene Delivery Devices Market Variables, Trends, & Scope
Chapter 4. Drug and Gene Delivery Devices Market: Route of Administration Estimates & Trend Analysis
Chapter 5. Drug and Gene Delivery Devices Market: Vector Estimates & Trend Analysis
Chapter 6. Drug and Gene Delivery Devices Market: Regional Estimates & Trend Analysis
Chapter 7. Competitive Landscape
Companies Mentioned
- Uniqure N.V.,
- SiBiono GeneTech Co.
- Epeius Biotechnologies Corporation
- Shanghai Sunway Biotech Co., Ltd
- Pfizer, Inc.
- F. Hoffmann-La Roche Ltd.
- Johnson and Johnson
- Novartis AG
- Bayer AG
- Becton, Dickinson and Company
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 100 |
| Published | August 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 670 Million |
| Forecasted Market Value ( USD | $ 1220 Million |
| Compound Annual Growth Rate | 9.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
